rfxcel Corporation has been selected by DCC Vital, a manufacturer headquartered in Dublin, Ireland,  to meet its European Falsified Medicines Directive (EU FMD) serialization requirements.

DCC Vital needed a serialization platform that could accommodate their diverse product offering, understand the need to keep their customers at the top of their focus, and allow them the flexibility to manage their environment based on their specifications.

“DCC Vital selected rfxcel for 3 reasons,” said Conor O’Shea, DCC Vital’s Head of Information Technology. “First, rfxcel is easy to work with. Throughout the evaluation process, rfxcel was very responsive and provided clear answers to our questions. Second, rfxcel offers a simple pricing model that is straight forward & transparent. Finally, rfxcel offers a customer focused architecture that allows us to manage a validated environment according to our quality standards and schedule.”

rfxcel offers fixed bid contracts, which ensures customers a clear insight into their pricing model, which is not the case when contracts are based on time and material bids.